Predicting response to neoadjuvant chemoradiotherapy in rectal cancer: from biomarkers to tumor models

Colorectal cancer (CRC) is a major contributor to cancer-associated morbidity worldwide and over one-third of CRC is located in the rectum. Neoadjuvant chemoradiotherapy (nCRT) followed by surgical resection is commonly applied to treat locally advanced rectal cancer (LARC). In this review, we summa...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Moying, Xiao, Qiyun, Venkatachalam, Nachiyappan, Hofheinz, Ralf-Dieter, Veldwijk, Marlon R., Herskind, Carsten, Ebert, Matthias P., Zhan, Tianzuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864271/
https://www.ncbi.nlm.nih.gov/pubmed/35222695
http://dx.doi.org/10.1177/17588359221077972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864271/
https://www.ncbi.nlm.nih.gov/pubmed/35222695
http://dx.doi.org/10.1177/17588359221077972

Ejemplares similares